Below you’ll find all of our archived press releases, articles written by the Crohn's & Colitis Foundation, as well as research articles from external media sources. You can also search for a specific news item or topic by using direct keywords (for example, “the foundation research”) or by filtering the news by date or category.
Please note: If you are a member of the media interested in speaking with a foundation's spokesperson, contact us today.
Team Challenge is CCFA's endurance training and fundraising program. When you join, you'll find new strength inside yourself, and help find cures for Crohn's and colitis.
Carrie Johnson is representing the United States at the 2012 Olympics in pursuit of the gold medal in women's kayaking. But while she battles for the gold, Johnson is fighting another battle: with Crohn's disease, one of the two most common inflammatory bowel diseases, according to the U.S. Centers for Disease Control and Prevention.
U.S. Olympic sprint kayaker Carrie Johnson and actor Ken Baumann shares their journey with Crohn's.
Eight leading IBD doctors, running as "Team Hope," will be suiting up for this year's national Team Challenge event: the Napa to Sonoma Wine Country Half Marathon. Many are members of CCFA's National Scientific Advisory Committee. And all of them started out as "relatively unfit people with no exercise regimen to speak of," according to Team Hope member Thomas Ullman, MD, a clinician and researcher at Mt. Sinai School of Medicine in New York City.
The U.S. Supreme Court on Thursday upheld the majority of the tenets of the Affordable Care Act. CCFA and its members have advocated for insurance reforms supporting increased access to care and therapies for all people with IBD and their families. The reforms in the Affordable Care Act reflect this important work.
Crohn’s & Colitis Foundation of America Unveils State-of-the-Art Website Geared Towards IBD Patients and the Medical CommunityJune 28, 2012
New York, NY (June 26, 2012): The Crohn’s & Colitis Foundation of America (CCFA), the nation’s leading nonprofit organization dedicated to curing Crohn’s disease and ulcerative colitis, is proud to introduce its newly designed website, www.ccfa.org.
According to the newest data presented at the 2012 DDW, there is no increased risk of birth defects among newborns of women who take certain biologic or immunomodulator therapy to control their Inflammatory Bowel Disease.
Bridgestone Americas, Inc CEO & President Gary A. Garfield Named First Ever National Take Steps Be Heard Walk ChairmanApril 30, 2012
The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce that Gary Garfield, President & CEO of Bridgestone Americas, Inc, will serve as the organization’s first ever National Chair for their Take Steps Be Heard walk program.
The Crohn’s & Colitis Foundation of America Named National Charity Beneficiary of the Lady Speed Stick® Women’s Half Marathon-NashvilleApril 2, 2012
The Crohn’s & Colitis Foundation of America has signed on as the National Beneficiary of the Lady Speed Stick® Women’s Half Marathon presented by Publix held in Nashville, Tennessee on Saturday, September 22, 2012.
The Crohn’s & Colitis Foundation of America Announces New National Board of Trustees Chair and Three New MembersMarch 6, 2012
The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce Maura C. Breen as its new National Board of Trustees Chair along with Donald Burke, John Crosson and Matt Leavitt, D.O., FAOCD as new members of the board.
Crohn’s & Colitis Foundation Honors Three Scientific Leaders for Exceptional Contributions to Field of Inflammatory Bowel DiseasesDecember 2, 2011
The Crohn’s & Colitis Foundation of America is proud to honor three leaders in the field of IBD research and treatment on Friday, December 2nd at its 2011 Advances in Inflammatory Bowel Diseases Clinical & Research Conference in Hollywood, Florida.
According to the newest data presented at the 2011 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference, the benefits of treating Inflammatory Bowel Disease (IBD) with the latest therapies outweigh the slightly increased risk associated with cancer.
The week of December 1-7 has been designated by the Crohn’s & Colitis Foundation of America (CCFA) as Crohn’s and Colitis Awareness Week in order to encourage all Americans to join in the effort to find cures for these diseases, help raise awareness and support research.
Congressional Crohn’s and Colitis Caucus Co-Chairmen Rep. Ander Crenshaw (R-FL) and Rep. Jesse Jackson, Jr., (D-IL) today (10/7) announced that the Caucus will hold its kick-off briefing on Wednesday, October 12.
ohnson & Johnson's Stelara helped a significantly higher percentage of Crohn's disease sufferers than those who received a placebo, according to a study of patients who had not been helped by other commonly used drugs.
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn's disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, as well as with azathioprine, and/or mercaptopurine.
A meta-analysis of randomized controlled trials (RCTs) supports the use of FDA-approved biological therapies in patients with active Crohn's disease or ulcerative colitis who have failed first- and second-line therapy or who are dependent on corticosteroids, researchers report.